Skip to content

The necessity of anti-tuberculosis therapy after resection of pulmonary tuberculous granuloma: a single center retrospective study

The necessity of anti-tuberculosis therapy after resection of pulmonary tuberculous granuloma: a single center retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019696
Enrollment
Unknown
Registered
2018-11-23
Start date
2018-12-10
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis

Interventions

A:Anti-tuberculosis treatment after operation
B:No anti-tuberculosis treatment after operation

Sponsors

Beijing Chest Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Asymptomatic solitary pulmonary nodules found in CT examination; 2. Preoperative sputum smear and anti-acid staining was negative, and no anti-tuberculosis treatment was performed before operation; 3. Pulmonary resection was performed, including thoracoscopy and thoracotomy. The resection range included wedge resection, segmentectomy, lobectomy and combined lobectomy; 4. The operation time was before December 2017; 5. Tuberculosis was diagnosed by postoperative pathology, including morphological diagnosis and molecular pathological diagnosis.

Exclusion criteria

Exclusion criteria: Patients lost for follow-up and without complete imaging data will be excluded

Design outcomes

Primary

MeasureTime frame
Relapse of tuberculosis;

Secondary

MeasureTime frame
Adverse reaction of anti-tuberculosis treatment;

Countries

China

Contacts

Public ContactLiu Shuku

Beijing Chest Hospital, Capital Medical University

liushuku@aliyun.com+86 010-89509307

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026